Schedule 13G ownership disclosure
BIOXCEL THERAPEUTICS INC
Common Stock, par value $0.001 · CUSIP: 09075P105
Event date: 2024-11-25
- Filing-level shares
- 2,724,075.00
- Percent of class
- 5.20%
- Qatar Investment Authority
Shares: 2,724,075.00 · Class: 5.20%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-001018
- Form type
- SCHEDULE 13G
- Filer
- BioXcel Therapeutics, Inc.
- CIK
- CIK 1720893
- Filed
- Dec 18, 2024
- Reporting period
- Nov 25, 2024
- Description
- Schedule 13G beneficial ownership